View more on these topics

Longbow launches Sipp venture fund

Longbow Capital, the healthcare venture investor has launched a Sipp venture fund.

The fund invests directly in health treatments enabling Sipp holders to invest in a professionally managed venture fund.

The fund has quarterly closing dates beginnning in March and a minimum subscription of £10,000 with multiples of £1,000 thereafter.

Investments made by Longbow include software for the visualisation of medical images in three dimensions for use by radiologists and for clinical trials and devices to help women’s insight into their breast health.

Initial commission for advisers is 2.5 per cent of the amount subscribed plus trail commission of 0.5 per cent per annum over the lifetime of the investment.

Longbow partner Julian Hickman says: “Investing in alternative investments needs to a key part of any investment strategy, yet until now Sipp investors have had little chance to access a venture fund exclusively designed for Sipps.

“Innovation in healthcare is being driven by over-burdened health services as they seek better treatments for patients. Longbow’s Sipp fund will invest in this rising tide of creativity.”



News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm